AERO: An AI Agent for Adaptive Eligibility Refinement and Optimization of Clinical Trial Criteria in Real-World Trial Emulation
Li, X.; James, J.; Pellikka, P. A.; Zong, N.
Show abstract
Randomized controlled trials (RCTs) provide high internal validity but often rely on restrictive eligibility criteria that limit generalizability and complicate real-world trial emulation. We propose AERO (AI Agent for Adaptive Eligibility Refinement and Optimization), an agentic framework that systematically adapts clinical trial eligibility criteria for application to electronic health record data. AERO integrates external clinical knowledge sources and large language model-based reasoning to classify criteria as strict inclusion, safety exclusion, confounder, or operational artifact. We evaluated AERO by emulating the WARCEF trial using Mayo Clinic Platform data restricted to the pre-trial completion period. Emulation with optimized criteria yielded a hazard ratio of 1.561 (p = 0.0605), consistent with the original neutral trial finding (HR = 1.01, p = 0.91). An ablation analysis demonstrated that eligibility handling decisions materially influence observed treatment effects. These results highlight the importance of systematic, knowledge-informed eligibility refinement in real-world evidence generation.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Natural language processing for scalable feature engineering and ultra-high-dimensional confounding adjustment in healthcare database studies 94%
- Automated Interpretable Discovery of Heterogeneous Treatment Effectiveness: A Covid-19 Case Study 93%
- Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance 93%
Similar papers in this journal
- A Scoping Review of Artificial Intelligence Applications in Clinical Trial Risk Assessment 94%
- Exploring the Feasibility of Using Real-World Data from a Large Clinical Data Research Network to Simulate Clinical Trials of Alzheimer’s Disease 93%
- Aggregating Multiple Real-World Data Sources using a Patient-Centered Health Data Sharing Platform: an 8-week Cohort Study among Patients Undergoing Bariatric Surgery or Catheter Ablation of Atrial Fibrillation 93%
Similar papers in this journal
- Approaches in Analyzing Predictors of Trial Failure: A Scoping Review and Meta-epidemiological study 93%
- External control arm analysis: an evaluation of propensity score approaches, G-computation, and doubly debiased machine learning 93%
- Comparing randomized trial designs to estimate treatment effect in rare diseases with longitudinal models: a simulation study showcased by Autosomal Recessive Cerebellar Ataxias using the SARA score 93%
Similar papers in this journal
- A modular pipeline for natural language processing-screened human abstraction of a pragmatic trial outcome from electronic health records 94%
- Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: a scoping review 93%
- Design and implementation of the multi-arm, multi-stage Therapeutics for Inpatients with COVID-19 (TICO) platform master protocol: An Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.